Ethics FORUM Elizabeth A. Kitsis, MD, MBE, Michele Meltzer, MD, MBE, and C. Ronald MacKenzie, MD | January 17, 2011Understanding the challenges in rheumatology today
Treat JIA Without Slowing Growth By Sue Pondrom | January 4, 2011Etanercept does not impede normal height and weight development in these patients
Macrophage Activation Syndrome Alexei A. Grom, MD | December 1, 2010A review of diagnosis, treatment, and prognosis
Immunizations and Autoimmune Disease Vanessa Caceres | December 1, 2010What is safe and what to avoid in this patient population
No Clear Connection Between Inflammation & Disease Progression in AS Kathy Holliman | October 1, 2010TNF blockers decrease symptoms but seem to have little impact on structural damage
Are We Playing It Safe? Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010Tumor necrosis factor alpha inhibition and the risk of solid malignancies
TNF Blockade for SLE Martin Aringer, MD, and Maria Dall’Era, MD | September 1, 2010Reckless approach versus missed opportunity?
Meet the Model Biologics Policy From the College | July 1, 2010At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
RA Therapy Can Increase Risk for Lung Disease Kathy Holliman | April 1, 2010Vigilant screening for NTM lung disease and latent tuberculosis needed